Monte Rosa Therapeutics (GLUE) Treasury Shares (2020 - 2026)

Monte Rosa Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 28.48% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 28.48% YoY), while the FY2025 annual figure was $775765.0, up 591.67% from the prior year.
• Treasury Shares was $1.1 million for Q1 2026 at Monte Rosa Therapeutics, up from $775765.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.1 million in Q1 2026 to a low of $624.0 in Q3 2024.
• Historically, Treasury Shares has averaged $342884.8 across 5 years, with a median of $189316.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares sank 98.19% in 2024, then soared 124046.63% in 2025.
• A 5-year view of Treasury Shares shows it stood at $122271.0 in 2022, then surged by 93.44% to $236519.0 in 2023, then sank by 52.58% to $112159.0 in 2024, then surged by 591.67% to $775765.0 in 2025, then soared by 48.11% to $1.1 million in 2026.
• The last three Treasury Shares figures came in at $1.1 million (Q1 2026), $775765.0 (Q4 2025), and $774675.0 (Q3 2025), per Business Quant data.